The endotoxin-induced plasminogen activator inhibitor-1 increase in rabbits is not tumor necrosis factor-alpha dependent and can occur in the absence of interleukin-1beta

Thromb Haemost. 2002 Oct;88(4):639-43.

Abstract

The plasminogen activator inhibitor-1 (PAI-1)-dependent fibrinolytic inhibition occurring in endotoxemia contributes to disseminated intravascular coagulation (DIC). Previous findings suggest that tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) are responsible for the increase in the level of PAI-1. These observations usually arose from mild endotoxemia models. We analyzed the effect of FR167653, an inhibitor of the TNF-alpha/IL-1beta production, on the PAI-1 levels in rabbits given endotoxin at a dose sufficient to induce DIC: the steep plasma PAI-1 increase was not attenuated by FR167653, in spite of achieving efficient inhibition of the TNF-alpha production. No IL-1beta was detected during endotoxemia. These results suggest that PAI-1 increase might be independent of TNF-alpha and IL-1beta. If these findings applied to humans, therapeutic intervention directing these cytokines would not be useful for the treatment of fibrinolysis in patients with severe sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disseminated Intravascular Coagulation / chemically induced
  • Disseminated Intravascular Coagulation / etiology
  • Disseminated Intravascular Coagulation / prevention & control
  • Endotoxemia / blood
  • Endotoxemia / complications
  • Endotoxemia / drug therapy
  • Endotoxins / administration & dosage
  • Endotoxins / pharmacology*
  • Fibrin / drug effects
  • Fibrin / metabolism
  • Interleukin-1 / blood
  • Interleukin-1 / physiology*
  • Kidney / blood supply
  • Kidney / pathology
  • Lipopolysaccharides / administration & dosage
  • Lipopolysaccharides / pharmacology
  • Lung / blood supply
  • Lung / pathology
  • Male
  • Plasminogen Activator Inhibitor 1 / blood*
  • Plasminogen Activator Inhibitor 1 / physiology
  • Pyrazoles / administration & dosage
  • Pyrazoles / pharmacology
  • Pyridines / administration & dosage
  • Pyridines / pharmacology
  • Rabbits
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / physiology*

Substances

  • Endotoxins
  • FR 167653
  • Interleukin-1
  • Lipopolysaccharides
  • Plasminogen Activator Inhibitor 1
  • Pyrazoles
  • Pyridines
  • Tumor Necrosis Factor-alpha
  • Fibrin